CSIMarket
 


Corvus Pharmaceuticals Inc   (CRVS)
Other Ticker:  
 

Cumulative Corvus Pharmaceuticals Inc 's Leverage Ratio for Trailing Twelve Months Period

CRVS's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

CRVS Leverage Ratio for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth -31.06 % -31.53 % -38.44 % -45.54 % -42.25 %
Y / Y Total Liabilities Growth -43.35 % -51.15 % -29.59 % -19.35 % -1.37 %
Leverage Ratio for Trailing Twelve Months Period 0.18 0.19 0.21 0.2 0.18
Total Ranking # 183 # 383 # 479 # 481 # 513
Seq. Equity Growth -12.66 % -10.5 % 1.26 % -12.92 % -13.24 %
Seq. Total Liabilities Growth -10.24 % -10.57 % -8.27 % -23.05 % -22.61 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Due to debt repayement of -10.24% Corvus Pharmaceuticals Inc decreased Leverage Ratio for Trailing Twelve Months Period in the IV. Quarter to 0.18, above Corvus Pharmaceuticals Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 45 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Corvus Pharmaceuticals Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are CRVS's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 46
Sector # 79
S&P 500 # 180


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.24 0.15 0.08
(Dec 31 2020)   (Dec 31 2018)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Acurx Pharmaceuticals inc   0.49 
Hookipa Pharma inc   0.48 
Cue Biopharma Inc   0.48 
Legend Biotech Corporation  0.48 
Arcturus Therapeutics Holdings Inc   0.47 
Geron Corp  0.47 
Blue Water Biotech Inc   0.47 
Xoma Corporation  0.46 
Thorne Healthtech Inc   0.46 
Imunon Inc   0.45 
Theriva Biologics inc   0.45 
Roivant Sciences Ltd   0.44 
Pulmatrix Inc   0.44 
Mainz Biomed N v   0.44 
Nurix Therapeutics Inc   0.43 
Enanta Pharmaceuticals Inc  0.43 
Verrica Pharmaceuticals Inc   0.43 
Mereo Biopharma Group Plc  0.42 
Medicure Inc   0.42 
Inhibitor Therapeutics Inc   0.42 
Vera Therapeutics Inc   0.42 
Sinovac Biotech Ltd  0.41 
Oncolytics Biotech Inc   0.41 
Merus N v   0.41 
Integrated Biopharma Inc  0.41 
Calithera Biosciences Inc   0.41 
Opko Health Inc   0.40 
Kamada Ltd   0.40 
Centessa Pharmaceuticals Plc  0.40 
Alpine Immune Sciences Inc   0.39 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com